Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study (Q46531465)
Jump to navigation
Jump to search
scientific article published on 6 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study |
scientific article published on 6 June 2005 |
Statements
1 reference
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study (English)
1 reference
Mitchell Machtay
1 reference
David S Ettinger
1 reference
Brian A Berkey
1 reference
Ross A Abrams
1 reference
James Fontanesi
1 reference
Philip J Duncan
1 reference
Walter J Curran
1 reference
Benjamin Movsas
1 reference
Roger W Byhardt
1 reference
Radiation Therapy Oncology Group 9609
1 reference
6 June 2005
1 reference
23
1 reference
22
1 reference
4991-4998
1 reference